R. Matulionytė

发表

A Randomized Prospective Study of Cefepime Plus Metronidazole with Imipenem-Cilastatin in the Treatment of Intra-abdominal Infections

P. Morel, J. Garbino, P. Villiger, 2007, Infection.

Oral manifestations of HIV disease: A review.

R. Matulionytė, Daiva Aškinytė, Arūnas Rimkevičius, 2015, Stomatologija.

Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program

I. Grant, T. Harrer, D. Podzamczer, 2013 .

Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data.

R. Steele, J. Sejvar, J. Galama, 2007, Vaccine.

Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

C. Leen, A. Mocroft, O. Kirk, 2017, HIV medicine.

Secular trends of nocardia infection over 15 years in a tertiary care hospital

J. Garbino, I. Uçkay, D. Lew, 2004, Journal of Clinical Pathology.

The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group

A. Horban, I. Karpov, R. Matulionytė, 2022, Viruses.

Should we continue using amphotericin B deoxycholate for the treatment of fungal infections? Adverse events and clinical outcomes

J. Garbino, D. Lew, R. Matulionytė, 2005, Scandinavian journal of infectious diseases.

Increased integrated testing for HIV, hepatitis C and sexually transmitted infections in health care facilities: results from the INTEGRATE Joint Action pilots in Lithuania, Romania and Spain

A. Sullivan, D. Raben, R. Matulionytė, 2021, BMC Infectious Diseases.

National multi-stakeholder meetings: a tool to support development of integrated policies and practices for testing and prevention of HIV, viral hepatitis, TB and STIs

S. F. Jakobsen, Piotr Wysocki, M. Maffeo, 2021, BMC Infectious Diseases.

The hepatitis C cascade of care in HIV/hepatitis C virus coinfected individuals in Europe: regional and intra-regional differences

A. Mocroft, J. Lazarus, J. Lundgren, 2021, AIDS.

The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease—A report from Central and Eastern Europe

R. Matulionytė, N. Yancheva, J. Kowalska, 2020, International Journal of Infectious Diseases.

Do medical students feel prepared to prescribe antibiotics responsibly? Results from a cross-sectional survey in 29 European countries

O. Dyar, G. Barlow, D. Nathwani, 2018, Journal of Antimicrobial Chemotherapy.

Successful use of extracorporeal membrane oxygenation in a human immunodeficiency virus infected patient with severe acute respiratory distress syndrome

D. Ringaitiene, J. Šipylaitė, L. Griškevičius, 2014, AIDS Research and Therapy.

Disseminated histoplasmosis in an HIV-infected patient discovered by routine blood smear staining

B. Hirschel, J. Garbino, I. Uçkay, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Retrospective analysis of the etiology, clinical characteristics and outcomes of community-acquired bacterial meningitis in the University Infectious Diseases Centre in Lithuania

S. Kiverytė, R. Matulionytė, E. Matulyte, 2020, BMC Infectious Diseases.

Routine HIV testing program in the University Infectious Diseases Centre in Lithuania: a four-year analysis

A. Ambrozaitis, R. Matulionytė, K. Zagminas, 2019, BMC Infectious Diseases.

HIV care in times of the COVID-19 crisis — Where are we now in Central and Eastern Europe?

A. Horban, R. Matulionytė, N. Chkhartishvili, 2020, International Journal of Infectious Diseases.

HCV reinfection after HCV therapy among HIV/HCV‐coinfected individuals in Europe

A. Mocroft, H. Stellbrink, J. Lundgren, 2021, HIV medicine.

The EuroSIDA study: 25 years of scientific achievements

A. Mocroft, O. Kirk, A. d’Arminio Monforte, 2019, HIV medicine.

Uptake of hepatitis C virus treatment in HIV/hepatitis C virus-coinfected patients across Europe in the era of direct-acting antivirals

C. Leen, A. Mocroft, J. Gatell, 2018, AIDS.

Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study

C. Leen, A. Mocroft, J. Lundgren, 2021, JAIDS Journal of Acquired Immune Deficiency Syndromes.

Effectiveness and safety of IFN-free DAA HCV therapy in HIV/HCV co-infected persons: Results from a pan-European study.

C. Leen, A. Mocroft, J. Lundgren, 2020, Journal of acquired immune deficiency syndromes.

National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review

A. Giacomelli, A. Sullivan, S. F. Jakobsen, 2022, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

Uptake and effectiveness of two-drug compared to three-drug antiretroviral Regimens among HIV-positive Individuals in Europe.

A. Mocroft, J. Lundgren, V. Vullo, 2019, AIDS.

The socio-demographic, clinical characteristics and outcomes of tuberculosis among HIV infected adults in Lithuania: A thirteen-year analysis

D. Costagliola, J. Urbonienė, R. Matulionytė, 2023, PloS one.

Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group

A. Horban, J. Tomažič, R. Matulionytė, 2020, HIV medicine.

PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future

J. Tomažič, R. Matulionytė, I. Alexiev, 2023, Vaccines.

The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group

A. Horban, J. Tomažič, R. Matulionytė, 2022, International journal of environmental research and public health.

National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region

J. Tomažič, R. Matulionytė, J. Begovac, 2021, HIV medicine.

Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium

A. Mocroft, J. Gallant, F. Wit, 2022, HIV medicine.

Two dog-related infections leading to death: overwhelming Capnocytophaga canimorsus sepsis in a patient with cystic echinococcosis.

A. Ambrozaitis, R. Matulionytė, Ingrida Lisauskienė, 2012, Medicina.

The Case Series of 34 Patients with COVID-19 Diagnosed with HIV Infection from Central and Eastern European Countries – Euroguidelines in Central and Eastern Europe Network Group Data

A. Horban, R. Matulionytė, N. Yancheva, 2020 .

Retrospective evaluation of an observational cohort by the Central and Eastern Europe Network Group shows a high frequency of potential drug–drug interactions among HIV‐positive patients receiving treatment for coronavirus disease 2019 (COVID‐19)

R. Matulionytė, J. Begovac, N. Yancheva, 2021, HIV medicine.

Associations between HIV-RNA-based indicators and virological and clinical outcomes

A. Mocroft, O. Kirk, J. Lundgren, 2016, AIDS.

Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV.

R. Haubrich, C. Leen, A. Mocroft, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long‐term effectiveness of recommended boosted protease inhibitor‐based antiretroviral therapy in Europe

A. Mocroft, A. Blaxhult, J. Lundgren, 2018, HIV medicine.